Literature DB >> 2059626

Functional and structural characterization of peptidylamidoglycolate lyase, the enzyme catalyzing the second step in peptide amidation.

A G Katopodis1, D S Ping, C E Smith, S W May.   

Abstract

Carboxy-terminal amidation is a prevalent posttranslational modification necessary for the bioactivity of many neurohormonal peptides. We recently reported that in addition to peptidylglycine alpha-monooxygenase (PAM), a second enzyme, which we now call peptidylamidoglycolate lyase (PGL), functions in the enzymatic formation of amides [Katopodis et al. (1990) Biochemistry 29, 4551]. The monooxygenase first catalyzes formation of the alpha-hydroxyglycine derivative of the glycine-extended precursor, and the lyase subsequently catalyzes breakdown of the PAM product to the amidated peptide and glyoxylate. We report here the first primary sequence data for PGL, which establish that it is part of the putative protein precursor which also contains PAM. We also show that PAM and PGL activities are colocalized in the secretory granular fraction of neurointermediate pituitary as would be expected for enzymes sharing the same precursor. Time course studies of the amidation reaction using purified soluble pituitary PAM and PGL indicate that both enzymes are essential for enzymatic amidation. Finally, PGL has no effect on the substrate or inhibition kinetics of PAM, and purified pituitary PAM has an acidic pH optimum consistent with its known localization in secretory granules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059626     DOI: 10.1021/bi00239a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Prediction of protein amidation sites by feature selection and analysis.

Authors:  Weiren Cui; Shen Niu; Lulu Zheng; Lele Hu; Tao Huang; Lei Gu; Kaiyan Feng; Ning Zhang; Yudong Cai; Yixue Li
Journal:  Mol Genet Genomics       Date:  2013-06-21       Impact factor: 3.291

2.  The source of the oxygen atom in the alpha-hydroxyglycine intermediate of the peptidylglycine alpha-amidating reaction.

Authors:  M Noguchi; H Seino; H Kochi; H Okamoto; T Tanaka; M Hirama
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

3.  Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation.

Authors:  A S Kolhekar; M S Roberts; N Jiang; R C Johnson; R E Mains; B A Eipper; P H Taghert
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

4.  Two alternative processing pathways for a preprohormone: a bioactive form of secretin.

Authors:  V Bonetto; H Jörnvall; V Mutt; R Sillard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  Kinetic and stereochemical studies on novel inactivators of C-terminal amidation.

Authors:  J Feng; J Shi; S R Sirimanne; C E Mounier-Lee; S W May
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

6.  Identification, isolation, and characterization of daintain (allograft inflammatory factor 1), a macrophage polypeptide with effects on insulin secretion and abundantly present in the pancreas of prediabetic BB rats.

Authors:  Z W Chen; B Ahren; C G Ostenson; A Cintra; T Bergman; C Möller; K Fuxe; V Mutt; H Jörnvall; S Efendic
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Kinetic and inhibition studies on substrate channelling in the bifunctional enzyme catalysing C-terminal amidation.

Authors:  A B Moore; S W May
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

8.  Amidation of bioactive peptides: the structure of the lyase domain of the amidating enzyme.

Authors:  Eduardo E Chufán; Mithu De; Betty A Eipper; Richard E Mains; L Mario Amzel
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

9.  NN-dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine alpha-amidating mono-oxygenase catalysis.

Authors:  C Li; C D Oldham; S W May
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

10.  Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophages.

Authors:  Jacob D Lucrezi; Timothy J Burns; Diane F Matesic; Charlie D Oldham; Sheldon W May
Journal:  Int Immunopharmacol       Date:  2014-04-18       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.